Barrett & Company’s Merck MRK Stock Holding History

Barrett & Company’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$695K	Buy	5,411 +715	+15%	+$83.7K	0.19%	79
2026 Q1	$565K	Sell	4,696 -468	-9%	-$54K	0.19%	75
2025 Q4	$544K	Sell	5,164 -1,000	-16%	-$93.9K	0.18%	82
2025 Q3	$517K	Sell	6,164 -534	-8%	-$44K	0.18%	83
2025 Q2	$530K	Buy	6,698 +471	+8%	+$37.4K	0.2%	79
2025 Q1	$559K	Sell	6,227 -318	-5%	-$29.7K	0.24%	72
2024 Q4	$651K	Buy	6,545 +250	+4%	+$25.8K	0.27%	63
2024 Q3	$715K	Sell	6,295 -515	-8%	-$61.2K	0.31%	58
2024 Q2	$843K	Sell	6,810 -70	-1%	-$9.02K	0.38%	50
2024 Q1	$908K	Sell	6,880 -130	-2%	-$16K	0.43%	43
2023 Q4	$764K	Sell	7,010 -136	-2%	-$14.1K	0.41%	51
2023 Q3	$736K	Buy	7,146 +322	+5%	+$34.7K	0.43%	47
2023 Q2	$787K	Hold	6,824	–	–	0.46%	46
2023 Q1	$726K	Sell	6,824 -40	-0.6%	-$4.32K	0.46%	46
2022 Q4	$762K	Hold	6,864	–	–	0.5%	46
2022 Q3	$762K	Buy	+6,864	New	+$613K	0.5%	46

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Barrett & Company's MRK Position: Q2 2026 in Review

Barrett & Company increased its Merck (MRK) stake by 15% in Q2 2026, buying an estimated $83.7K and bringing the position to 5,411 shares worth $695K. The position accounts for 0.19% of the portfolio, ranked #79.

Barrett & Company first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. The position peaked at $908K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Barrett & Company held 5,411 shares of Merck worth $695K as of Q2 2026.
Barrett & Company bought 715 Merck shares in Q2 2026, an estimated $83.7K.
Merck made up 0.19% of Barrett & Company's portfolio in Q2 2026, its #79 holding.
Barrett & Company first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
Barrett & Company's Merck position peaked at $908K in Q1 2024.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.